1. Home
  2. DRTS vs PCN Comparison

DRTS vs PCN Comparison

Compare DRTS & PCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alpha Tau Medical Ltd.

DRTS

Alpha Tau Medical Ltd.

HOLD

Current Price

$12.68

Market Cap

978.2M

Sector

Health Care

ML Signal

HOLD

Logo Pimco Corporate & Income Strategy Fund

PCN

Pimco Corporate & Income Strategy Fund

HOLD

Current Price

$11.88

Market Cap

881.0M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
DRTS
PCN
Founded
2015
N/A
Country
Israel
United States
Employees
121
N/A
Industry
Medical/Dental Instruments
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
978.2M
881.0M
IPO Year
N/A
2001

Fundamental Metrics

Financial Performance
Metric
DRTS
PCN
Price
$12.68
$11.88
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$8.67
N/A
AVG Volume (30 Days)
812.0K
307.3K
Earning Date
05-18-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$699.98
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.87
$11.40
52 Week High
$14.11
$13.49

Technical Indicators

Market Signals
Indicator
DRTS
PCN
Relative Strength Index (RSI) 63.84 54.22
Support Level $6.59 $11.45
Resistance Level N/A $12.09
Average True Range (ATR) 0.86 0.10
MACD 0.15 0.01
Stochastic Oscillator 70.26 60.26

Price Performance

Historical Comparison
DRTS
PCN

About DRTS Alpha Tau Medical Ltd.

Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as a localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company has active clinical programs targeting a range of different tumor types, such as head and neck cancer, pancreatic cancer, brain cancer, liver metastases, lung cancer, and prostate cancer. Geographically, it operates in Israel, United States, and Japan with the majority of the revenue generated from Israel.

About PCN Pimco Corporate & Income Strategy Fund

PIMCO Corporate & Income Strategy Fund is a closed-end management investment company. Its objective is to seek high current income with capital appreciation as a secondary objective. It invests in corporate bonds and notes, non-agency mortgage-backed securities, asset-backed securities, short-term instruments, and others.

Share on Social Networks: